|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B activation in Kupffer cell-depleted mice impairs liver regeneration after partial hepatectomy
1 Institute for Experimental Surgery, University of Rostock, Rostock, Germany
2 Department of Surgery, University of Bonn, Bonn, Germany
3 Institute of Clinical & Experimental Surgery, University of Saarland, Homburg/Saar, Germany
* To whom correspondence should be addressed. E-mail: brigitte.vollmar{at}med.uni-rostock.de.
Kupffer cells (KCs) are located in the liver sinusoids adjacent to hepatocytes and are capable of producing important growth-regulating mediators which exert both stimulatory and inhibitory influences on hepatocyte proliferation by paracrine mechanisms. To elucidate the overall effect of KC-depletion on liver regeneration, mice were selectively and long-standing depleted of KCs by liposome-encapsulated dichlormethylene diphosphonate. Using in vivo fluorescence microscopy, immunohistochemistry, Western blot analysis, NF-
B transcription factor DNA binding activity and cytokine assays, livers of KC-depleted and KC-competent mice were analyzed at day 3, 5 and 8 after partial, i.e. 68% hepatectomy (PH). Selective KC elimination delayed cell proliferation, as given by significantly reduced PCNA and cyclin B1 protein expression in liver tissue at day 3 post PH. This was associated with a lower liver weight at day 8 upon PH. Resection-associated activation of NF-
B with translocation into parenchymal and nonparenchymal cell nuclei was diminished in livers of KC-depleted mice, primarily at day 3 after PH. KC-depleted mice further lacked the resection-induced rise in TNF-
and IL-6 serum concentrations. These findings imply that KCs play a stimulatory role in liver regeneration, mainly by activating NF-
B with influence on the cell cycle, and by enhancing expression of the proliferative cytokines TNF-
and IL-6.
This article has been cited by other articles:
![]() |
N. Anderson and J. Borlak Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |